Skip to content

The innovation of minimally invasive technique and the standardization of treatment for benign prostatic hyperplasia and Technology promotion of Transuretbra suspended vapor enucleation of prostate with TURis button electrode

The innovation of minimally invasive technique and the standardization of treatment for benign prostatic hyperplasia and Technology promotion of Transuretbra suspended vapor enucleation of prostate with TURis button electrode

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16009454
Enrollment
Unknown
Registered
2016-10-16
Start date
2016-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperplasia

Interventions

1:The operative method is TURP
2:The operative method is TmLRP
3:The operative method is Transuretbra suspended vapor enucleation of prostate with TURis button electrode
4:The operative method is TUPK

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Moderate and severe BPH patients, accompanied by the symptoms of lower urinary tract obstruction(IPSS>10, QOL =4), affecting the quality of life; 2. BPH patients were examined by rectal ultrasound, measuring the volume of prostate in the range of 20 ~ 100ml; 3. Serum total PSA4ng/ml but biopsy excluded prostate cancer; 4. There is no serious medical disease, no bladder stones and tumors and other complications of the need for other surgical treatment.

Exclusion criteria

Exclusion criteria: 1. Neurogenic bladder and severe urinary tract infection; 2. postoperative pathological reports as Prostate cancer or prostatic intraethelial neoplasia(PIN); 3. Patients with poor compliance or other situations the researchers believe that is not eligible for inclusion.

Design outcomes

Primary

MeasureTime frame
IPSS score;Qmax;Complication rate;Operation time;IIEF-5 score;

Countries

China

Contacts

Public ContactBo Peng

Shanghai 10th People's Hospital

pengbo6908@163.com+86 18917683258

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026